Shares of IXICO PLC (LON: IXI) rallied 5.41% higher after winning a two-year contract worth over $750,000 to support a phase 2 Alzheimer’s disease clinical trial run by a leading global clinical research company.
The British clinical research company revealed that it would provide advanced imaging solutions over two years to the clinical research company.
Today’s contract is the second such contract unveiled this week after Ixico won a contract worth more than $500,000 from an unnamed US biopharmaceutical company to support its phase 2 Huntington’s disease clinical trial.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ixico shares have barely moved this week despite the two contract wins as investors remain mainly oblivious to the significant revenue opportunities created by the two deals.
We could also attribute the lack of traction in Ixico’s share price to its high share price, which is trading above 70p a share, hence, the muted reaction.
This month, the neuroimaging and digital biomarker analytics company has been on a roll, having won another phase 1 MSA contract award worth over $500,000 over four years, bringing its total contract wins to three, yet its stock price barely moved.
Earlier in August, Ixico noted that it expects to generate £8.7 million in revenue during the 2021 financial year, of which £1.2 million would be its gross profits before taxes.
It is unclear whether the recent contract wins will result in higher earnings, and investors will be watching the company for further clarification.
Ixico shares are currently trading 22.69% lower than they were at the start of the year. Ixico shares are currently trading within a wide trading range with no decent trade setups for short-term traders.
*This is not investment advice.
Ixico share price.
Ixico shares rallied 5.41% to trade at 78.0p, rising from Tuesday’s closing price of 74.0p.
